Clinical trial
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
NCT05442151 is registered in ClinicalTrials.gov with Tadashi Watabe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
- Lead sponsor
- Tadashi Watabe
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 9, 2022
- Completion date
- March 31, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.